UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-40047 Talis Biomedical Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction of in ...

Talis Biomedical Corporation (NASDAQ:TLIS) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Emily Faucette - SVP-Corporate Communications and IR Rob Kelley - CEO Roger Moody - CFO Conference Call Participants Rachel Vatnsdal - JPMorgan Derik De Bruin - Bank of America Mark Massaro - BTIG Operator Thank you all for standing by, and welcome to Talis's First Quarter 2022 Earnings Conference Call. [Operator Instructions] I'll now turn the call over to your host, Emily Faucette. Ma'a ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-40047 Talis Biomedical Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction of i ...

Talis Biomedical Corporation (OTC:TLIS) Q4 2021 Earnings Conference Call March 15, 2022 4:30 PM ET Corporate Participants Emily Faucette - Senior Vice President-Corporate Communications and Investor Relations Rob Kelly - Chief Executive Officer Roger Moody - Chief Financial Officer Conference Call Participants Derik De Bruin - Bank of America Mark Massaro - BTIG Operator Good day, and thank you for standing by, and welcome to the Talis Biomedical Fourth Quarter 2021 Earnings Conference Call. At this time, a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-40047 Talis Biomedical Corporation (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation or organization) 46-3122255 (I.R.S. Employer Identification No.) 230 Constitution Drive Menlo Park, California 94025 ( ...

Talis Biomedical Corporation (OTC:TLIS) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Emily Faucette - Senior Vice President-Corporate Communications and Investor Relations Kim Popovits - Interim Chief Executive Officer Rob Kelly - Chief Commercial Officer Doug Liu - Chief Operating Officer Roger Moody - Chief Financial Officer Conference Call Participants Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Operator Good day, ladies and gentlemen, and welcome to t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-40047 Talis Biomedical Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction ...

Talis Biomedical Corporation (OTC:TLIS) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Emily Faucette – Senior Vice President-Corporate Communications and Investor Relations Brian Coe – Chief Executive Officer Doug Liu – Chief Operating Officer Roger Moody – Chief Financial Officer Conference Call Participants Derik De Bruin – Bank of America Mark Massaro – BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the Talis Second Quarter 2021 Earnings Call. [Opera ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-40047 Talis Biomedical Corporation (Exact Name of Registrant as Specified in its Charter) WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Delaware (State or other jurisdiction of in ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Talis Biomedical Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or other jurisdiction of incorporation or organization) 230 Constitution Drive Menlo Park, California 94025 94025 (Address of principal executive officers) (Zip Code) Registrant's telep ...